Latest Growth Initiatives News

AVITA Medical closed 2025 with steady revenue growth and over 80% gross margin, setting the stage for a confident revenue forecast of up to US$85 million in 2026. The company also secured a new debt facility with improved terms, underpinning its growth ambitions.

Alkane Resources has reported record-breaking financial and operational results for the first half of FY2026, driven by strong gold and antimony production across its expanded three-mine portfolio. The company’s robust cash flow and profit position set a confident tone for meeting full-year guidance.

PeopleIN Limited has appointed co-founder Tom Reardon as its new CEO and Managing Director, signaling continuity in leadership as the company reports a robust unaudited EBITDA of $16.1 million.

Beacon Minerals has finalised the sale of its six Timor Leste concessions to Tivan Ltd, securing cash and equity to bolster its Australian gold operations and growth plans.

Civmec Limited has reported a robust first half for FY26, with strong revenue growth, a record order book, and significant progress in naval shipbuilding. The company’s diversified operations and strategic contracts position it well for future growth.

Webjet Group has ended acquisition discussions with Helloworld and BGH Capital, reaffirming its focus on executing its FY30 growth strategy while confirming FY26 EBITDA guidance and a $25 million share buy-back.

GQG Partners Inc. reported a 6.3% increase in net revenue and a 7.3% rise in net profit for 2025, alongside a strategic US ETF launch and a new dividend declaration.

Cochlear Limited posted a modest 1% increase in sales revenue for the half year ending December 2025, while underlying net profit fell 9%, impacted by cloud computing costs and a slower-than-expected Nexa System rollout. The company maintains its dividend and outlines cautious FY26 guidance.

Northern Star Resources has reported a robust half-year result with a 41% jump in net profit, driven by soaring gold prices despite operational setbacks. The company also announced a fully franked interim dividend of 25 cents per share.

Pro Medicus has reported its strongest half-year performance yet, with revenue and profits surging alongside a wave of new multi-million dollar contracts and strategic AI investments. The healthcare IT leader is expanding its global footprint and cloud capabilities, setting the stage for sustained growth.

Elixinol Wellness reported a 9.5% revenue increase in Q4 FY25 alongside a 30% reduction in operating costs, setting a clear path to profitability under fresh executive leadership.

Pro Medicus Limited has reported a stellar half-year performance with revenue up 28.4% and a surge in net profit, driven by major US contract wins and strategic investments.